FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and medicine, in particular to composition, which possesses bacteriostatic and bactericidal action and is intended for treatment of tuberculosis diseases. Pharmacological composition with anti-tuberculosis action contains active substances - anti-tuberculosis medications (ethambutol, isoniazid, rifampicin, pirazinamide) and as potentiating agent of synergetic action, enhancing impact of chemical preparations, stabilised nanoparticles of silver.
EFFECT: invention possesses properties allowing to inhibit medication-resistant strains of tuberculosis mycobacteria.
5 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
COMBINED MEDICATION OF ANTI-TUBERCULOSIS ACTION | 2008 |
|
RU2403050C2 |
METHOD FOR PREPARING ANTI-TUBERCULOSIS DRUG | 2010 |
|
RU2452498C2 |
PROPHYLACTIC AGENT FOR SKIN WITH ANTITUBERCULOUS EFFECT | 2009 |
|
RU2409367C2 |
COMBINED ANTITUBERCULAR PREPARATION AND METHOD FOR ITS OBTAINING | 2001 |
|
RU2182483C1 |
PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
ANTI-TUBERCULOSIS MEDICATION BASED ON 4-THIOUREIDOIMINOMETHYLPYRIDINIUM PERCHLORATE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2010 |
|
RU2423977C1 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2417087C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2422145C2 |
Authors
Dates
2011-02-27—Published
2008-08-26—Filed